Abstract:In the current Research Topic, Critical Complications in Pediatric Oncology and Hematopoietic Cell Transplant, Volume II, there is a continuation of the themes of improving outcomes and strengthening collaboration. This collection contains 21 publications from 195 authors representing 22 different countries on 5 continents (Figure 1). Volume II provides ongoing evidence that the field of pediatric onco-critical care is not going back to the era of the selffulfilling prophecy that critically ill children with cancer have abysmal outcomes rendering use of critical care resources futile.Knowing which HCT patients are at highest risk for requiring ICU care would be very valuable for clinicians. Using data from pediatric oncology patients in the Colorado Sepsis and Treatment Registry, serum lactate within 2 hours of presentation was found to be predictive of clinical deterioration events (OR 1.82, p<0.001), need for ICU admission (OR 1.68, p<0.001) and bacteremia (OR 1.49, p<0.001) [Slatnick et al]. Johnson et al performed a single center retrospective review of pediatric patients who received HCT at their institution between January 2015-December 2020 [Johnson et al]. Risk factors for PICU admission were: 1) younger age; 2) lower weight; 3) inborn error of metabolism as a reason for HCT and 4) use of busulfan conditioning. There was overlap in these results with those found by Zinter et al in a multi-center study merging the Center for International Bone Marrow Transplantation (CIBMTR) and Virtual PICU Performance System (VPS) databases. They also found younger age and inborn errors of metabolism as risk factors for requiring ICU care (17). However, there was disagreement where Zinter found pre-HCT organ dysfunction was associated with increased requirement for ICU admission, whereas Johnson did not. This may represent an improvement over time in managing complex patients during HCT versus differences in study design. A better understand organ dysfunction in these unique patients is imperative for continued improvements in outcomes.Accurate data surrounding the risks and benefits of ICU therapies will lead to better informed decisions regarding PICU interventions. In a retrospective single center study, Schober et al found that admissions for respiratory support (OR 1.04, p=0.04) and dialysis (OR 1.21, p=0.03) increased 6-month mortality compared to other reasons for PICU admission [Schober et al]. In a multi-variate analysis of pediatric oncology patients, hemato-oncology diagnosis, number of failing organs at baseline and unplanned admissions were associated with development of new or progressive multi-organ failure [Soeteman et al]. Data from the Health Facts (Cerner Corporation, Kansas City, MO) database containing 473 pediatric HCT patients found 11% required positive pressure ventilation, 25% received vasopressor medications and 3% received dialysis. Decreased survival was seen in allogeneic transplant (p<0.01), graft versus host disease (p=0.02), infection (p<0.01) and need for ICU therapies (p<0.01) [Olson et al]. Interestingly, survival improved over time for patients who received allogeneic transplants. The improved survival in the later era of the study was associated with decreased infections and increased use of vasopressor agents. The improvement in survival could represent a change in practice due to recent publications addressing the detrimental effects of fluid overload in HCT patients (16,18) with a shift towards earlier use of vasopressors rather than fluid resuscitation.Chimeric antigen receptor therapy, CAR-T, is being used in a growing number of cancers. However, it carries an increased risk for life threatening complications and critical illness. In a multi-center study, Ragoonanan et al compared PICU courses for pediatric ALL patients who were receiving conventional therapy vs those who received tisagenlecleucel [Ragoonanan et al]. They found PICU resource utilization between the 2 groups to be similar. The authors concluded that improved management of complications and need for ICU care should decline over time making CAR-T an important therapy to pursue, potentially beyond high resource settings.Cardenas-Aguirre et al show us that critically ill pediatric oncology patients in resource limited-settings can have PICU outcomes similar to those seen in high income countries [Cardenas-Aguirre et al]. In their dedicated pediatric oncology hospital in Mexico, they describe overall PICU mortality of 6.9% with mortality for unplanned PICU admissions of 9.1%. This is similar to that described in high income countries (19,20) The authors felt their center's low mortality was likely the result of implementing a number of quality improvement practices aimed at earlier recognition of deterioration allowing for earlier interventions.Endotheliopathy has been considered an underlying cause of multiple complications of HCT including sin -Abstract Truncated-

Treatment and prognosis of the patients with hematological diseases after chemotherapy and hematopoietic stem cell transplantation in ICU

[Clinical characteristics and prognosis in patients with high plasma level of procalcitonin: an analysis in 188 patients].

Risk factors and predictive model for mortality in patients undergoing allogeneic hematopoietic stem cell transplantation admitted to the intensive care unit

Application of Percutaneous Cardiopulmonary Support System in Critically Ill Patients

Prognostic Factors for Patients with Hematologic Malignancies Admitted to the Intensive Care Unit: is Allogeneic Transplantation Still a Risk Factor?

A retrospective observational study on outcome of post-hematopoietic stem cell transplant patients needing intensive care unit admission

Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients

Efficacy analysis of high-flux hemofiltration in the treatment of sepsis

Clinical Outcomes and Determinants of Survival in Patients with Hematologic Malignancies Admitted to Intensive Care Units with Critical Illness

Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant, volume II

Clinical analysis of continuous renal replacement therapy in patients with acute kidney injury in ICU

Investigation of the Possible Causes of NRBC in ICU Patients and the Dynamic Trend of NRBC Count in Survival and Death Patients or with Different Underlying Diseases: A Retrospective Study

Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients

Short- and Medium-Term Survival of Critically Ill Patients with Solid Cancer Admitted to the Intensive Care Unit

Analysis of Diagnosis and Treatment of 226 Cases with Severe Multiple Injuries in EICU

The Effect of the Underlying Malignancy on Short- and Medium-Term Survival of Critically Ill Patients Admitted to the Intensive Care Unit : A Retrospective Analysis Based on Propensity Score Matching

Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies

Evaluation of the treatment and survival chances in patients with solid organ tumors after discharge from the oncology hospital intensive care unit

Clinical Effect of Sub - hypothermia Treatment Combined with Hemopurification on Low Cardiac Output Syndrome in ICU

Analysis of Prognosis and Related Factors in Patients Admitted in EICU

Pulmonary function as a continuum of risk: critical care utilization and survival after allogeneic hematopoietic stem cell transplantation - a multicenter cohort study